Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia - Related Studies

Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia

This study has been completed.

Study NCT00078481. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Friedreich Ataxia

2	Additional conditions recognized in this trial
		Ataxia

3	More general conditions related to this trial
		Brain Diseases
		Central Nervous System Diseases
		Cerebellar Diseases
		Dyskinesias
		Genetic Diseases, Inborn
		Heredodegenerative Disorders, Nervous System
		Metabolic Diseases
		Mitochondrial Diseases
		Nervous System Diseases
		Neurodegenerative Diseases
		Neurologic Manifestations
		Signs and Symptoms
		Spinal Cord Diseases
		Spinocerebellar Degenerations

4	Interventions listed in this trial
		Idebenone

5	More general drug interventions related to this trial
		Antioxidants
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents

6	Sponsors listed in this trial
		National Institute of Neurological Disorders and Stroke (NINDS)